48,833
edits
Difference between revisions of "Adenocarcinoma of the lung"
Jump to navigation
Jump to search
Adenocarcinoma of the lung (view source)
Revision as of 17:15, 20 December 2016
, 17:15, 20 December 2016→IHC
(→www) |
(→IHC) |
||
| Line 187: | Line 187: | ||
*TTF-1 +ve. | *TTF-1 +ve. | ||
*[[Napsin]] A +ve. | *[[Napsin]] A +ve. | ||
*p40 -ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | *[[p40]] -ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | ||
*CK5/6 -ve. | *CK5/6 -ve. | ||